Trial Outcomes & Findings for Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression (NCT NCT06119854)
NCT ID: NCT06119854
Last Updated: 2025-09-11
Results Overview
Following our theoretical premise that our intervention will impact the uptake of COVID-19 vaccination, the investigators define our primary outcome as self-reported receipt of a COVID vaccine dose in the 4 weeks post-intervention. Risk ratios will be used to estimate and compare the proportion of participants in each arm who achieved the outcome. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances and conduct a mediation analysis to better understand the intervention's mechanisms of action.
COMPLETED
NA
1419 participants
4 weeks post-intervention
2025-09-11
Participant Flow
Overall, 2,411 CHASING COVID Cohort participants were invited, and 1,419 (59%) were eligible and randomized to the intervention. After completing the 4-week survey, 16 participants were removed from the sample based on data quality protocols, leaving an analytic sample of 1403 participants. Randomization resulted in 469 individuals in CBT-kernels arm, 466 in the Inoculation arm, and 468 in the Standard public health messaging arm
Participant milestones
| Measure |
Attitudinal Inoculation Intervention
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Cognitive Behavioral Therapy-informed Intervention
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Conventional Public Health Messaging
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.
Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
|---|---|---|---|
|
Overall Study
STARTED
|
472
|
473
|
474
|
|
Overall Study
COMPLETED
|
466
|
469
|
468
|
|
Overall Study
NOT COMPLETED
|
6
|
4
|
6
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression
Baseline characteristics by cohort
| Measure |
Attitudinal Inoculation Intervention
n=466 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Cognitive Behavioral Therapy-informed Intervention
n=469 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Conventional Public Health Messaging
n=468 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.
Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Total
n=1403 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
415 Participants
n=5 Participants
|
416 Participants
n=7 Participants
|
415 Participants
n=5 Participants
|
1246 Participants
n=4 Participants
|
|
Age, Categorical
>=65 years
|
51 Participants
n=5 Participants
|
53 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
157 Participants
n=4 Participants
|
|
Sex/Gender, Customized
Gender : Male
|
183 Participants
n=5 Participants
|
192 Participants
n=7 Participants
|
199 Participants
n=5 Participants
|
574 Participants
n=4 Participants
|
|
Sex/Gender, Customized
Gender : Female
|
263 Participants
n=5 Participants
|
270 Participants
n=7 Participants
|
254 Participants
n=5 Participants
|
787 Participants
n=4 Participants
|
|
Sex/Gender, Customized
Gender : Non-binary
|
20 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
42 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic
|
78 Participants
n=5 Participants
|
84 Participants
n=7 Participants
|
84 Participants
n=5 Participants
|
246 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · White (non-Hispanic)
|
268 Participants
n=5 Participants
|
288 Participants
n=7 Participants
|
286 Participants
n=5 Participants
|
842 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Black (non-Hispanic)
|
60 Participants
n=5 Participants
|
49 Participants
n=7 Participants
|
42 Participants
n=5 Participants
|
151 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Asian/American Indian/Pacific (non-Hispanic)
|
46 Participants
n=5 Participants
|
34 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
120 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Other/unknown
|
14 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
44 Participants
n=4 Participants
|
|
Region of Enrollment
United States · MidWest
|
72 Participants
n=5 Participants
|
76 Participants
n=7 Participants
|
84 Participants
n=5 Participants
|
232 Participants
n=4 Participants
|
|
Region of Enrollment
United States · NorthEast
|
113 Participants
n=5 Participants
|
127 Participants
n=7 Participants
|
134 Participants
n=5 Participants
|
374 Participants
n=4 Participants
|
|
Region of Enrollment
United States · South
|
167 Participants
n=5 Participants
|
163 Participants
n=7 Participants
|
135 Participants
n=5 Participants
|
465 Participants
n=4 Participants
|
|
Region of Enrollment
United States · Other
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
|
Region of Enrollment
United States · West
|
113 Participants
n=5 Participants
|
102 Participants
n=7 Participants
|
114 Participants
n=5 Participants
|
329 Participants
n=4 Participants
|
|
Number of COVID-19 vaccine doses as of Dec 2023
|
3.00 vaccine doses
n=5 Participants
|
3.00 vaccine doses
n=7 Participants
|
3.00 vaccine doses
n=5 Participants
|
3.00 vaccine doses
n=4 Participants
|
PRIMARY outcome
Timeframe: 4 weeks post-interventionPopulation: Overall, 2,411 CHASING COVID Cohort participants were invited, and 1,419 (59%) were eligible and randomized to the intervention. After completing the 4-week survey, 16 participants were removed from the sample based on data quality protocols, leaving an analytic sample of 1403 participants. Randomization resulted in 469 individuals in CBT-kernels arm, 466 in the Inoculation arm, and 468 in the Standard public health messaging arm (Figure 1).
Following our theoretical premise that our intervention will impact the uptake of COVID-19 vaccination, the investigators define our primary outcome as self-reported receipt of a COVID vaccine dose in the 4 weeks post-intervention. Risk ratios will be used to estimate and compare the proportion of participants in each arm who achieved the outcome. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances and conduct a mediation analysis to better understand the intervention's mechanisms of action.
Outcome measures
| Measure |
Attitudinal Inoculation Intervention
n=466 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Cognitive Behavioral Therapy-informed Intervention
n=469 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Conventional Public Health Messaging
n=468 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.
Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
|---|---|---|---|
|
Self-reported Receipt of COVID Vaccine Dose by 4 Weeks Post-intervention
Received vaccine
|
4 Participants
|
7 Participants
|
6 Participants
|
|
Self-reported Receipt of COVID Vaccine Dose by 4 Weeks Post-intervention
Did not receive vaccine
|
462 Participants
|
462 Participants
|
462 Participants
|
SECONDARY outcome
Timeframe: 4 weeks post-interventionPopulation: Of the 1,403 participants analyzed at baseline, 59 participants were lost to follow up (20 in CBT arm, 21 in inoculation arm, and 18 in standard arm)
The investigators will estimate vaccine hesitancy at baseline, immediately post-intervention, 4 weeks post-intervention, and at 6 months post-intervention. People who indicate that they are "not willing" to get a vaccine dose will be defined as vaccine resistant, people who indicate that they are "somewhat willing" will be described as vaccine hesitant, and people who report that they are "very willing" or who report having received a vaccine dose will be classified as vaccine willing. Risk ratios will be used to estimate and compare the proportion of participants in each arm who are either vaccine resistant or vaccine hesitant to those who are vaccine willing at each time point. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances.
Outcome measures
| Measure |
Attitudinal Inoculation Intervention
n=445 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Cognitive Behavioral Therapy-informed Intervention
n=449 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Conventional Public Health Messaging
n=450 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.
Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
|---|---|---|---|
|
Participants Classified as Vaccine Willing
|
168 Participants
|
138 Participants
|
139 Participants
|
SECONDARY outcome
Timeframe: 6 months post-interventionPopulation: Of the 1,403 participants analyzed, 74 were lost to follow up by month 6 (25 in CBT arm, 23 in inoculation arm, and 26 in standard arm)
The investigators define our outcome as self-reported receipt of a COVID vaccine dose in the 6 months post-intervention. Risk ratios will be used to estimate and compare the proportion of participants in each arm who achieved the outcome. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances and conduct a mediation analysis to attempt to better understand the intervention's mechanisms of action.
Outcome measures
| Measure |
Attitudinal Inoculation Intervention
n=443 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Cognitive Behavioral Therapy-informed Intervention
n=444 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Conventional Public Health Messaging
n=411 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.
Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
|---|---|---|---|
|
Self-reported Receipt of a COVID Vaccine Dose by 6 Months Post-intervention
|
72 Participants
|
61 Participants
|
57 Participants
|
SECONDARY outcome
Timeframe: 6-months post-interventionPopulation: Of the 1,403 participants analyzed at baseline, 76 participants were lost to follow up by month 6 (26 in CBT arm, 23 in inoculation arm, and 27 in standard arm)
The investigators will estimate vaccine hesitancy at baseline, immediately post-intervention, 4 weeks post-intervention, and at 6 months post-intervention. People who indicate that they are "not willing" to get a vaccine dose will be defined as vaccine resistant, people who indicate that they are "somewhat willing" will be described as vaccine hesitant, and people who report that they are "very willing" or who report having received a vaccine dose will be classified as vaccine willing. Risk ratios will be used to estimate and compare the proportion of participants in each arm who are either vaccine resistant or vaccine hesitant to those who are vaccine willing at each time point. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances.
Outcome measures
| Measure |
Attitudinal Inoculation Intervention
n=443 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Cognitive Behavioral Therapy-informed Intervention
n=443 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Conventional Public Health Messaging
n=441 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.
Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
|---|---|---|---|
|
Vaccine Willingness Post-intervention
|
202 Participants
|
172 Participants
|
152 Participants
|
SECONDARY outcome
Timeframe: immediately post-interventionThe investigators will estimate vaccine hesitancy at baseline, immediately post-intervention, 4 weeks post-intervention, and at 6 months post-intervention. People who indicate that they are "not willing" to get a vaccine dose will be defined as vaccine resistant, people who indicate that they are "somewhat willing" will be described as vaccine hesitant, and people who report that they are "very willing" or who report having received a vaccine dose will be classified as vaccine willing. Risk ratios will be used to estimate and compare the proportion of participants in each arm who are either vaccine resistant or vaccine hesitant to those who are vaccine willing at each time point. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances.
Outcome measures
| Measure |
Attitudinal Inoculation Intervention
n=466 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Cognitive Behavioral Therapy-informed Intervention
n=469 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
Conventional Public Health Messaging
n=468 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.
Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
|
|---|---|---|---|
|
Vaccine Willingness Post-intervention
|
153 Participants
|
133 Participants
|
141 Participants
|
Adverse Events
Attitudinal Inoculation Intervention
Cognitive Behavioral Therapy-informed Intervention
Conventional Public Health Messaging
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place